| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1982PNAS...79.3637D |
| P356 | DOI | 10.1073/PNAS.79.11.3637 |
| P932 | PMC publication ID | 346478 |
| P698 | PubMed publication ID | 6285355 |
| P5875 | ResearchGate publication ID | 16911635 |
| P2093 | author name string | C J Der | |
| G M Cooper | |||
| T G Krontiris | |||
| P2860 | cites work | Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 |
| Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate | Q29618203 | ||
| Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin | Q33980315 | ||
| Transformation of mammalian cells with genes from procaryotes and eucaryotes | Q34030262 | ||
| Human-tumor-derived cell lines contain common and different transforming genes | Q34245850 | ||
| Nucleotide sequence of the rightward operator of phage lambda | Q35074385 | ||
| Structure of the provirus within NIH 3T3 cells transfected with Harvey sarcoma virus DNA | Q35236938 | ||
| Structure and functions of the Kirsten murine sarcoma virus genome: molecular cloning of biologically active Kirsten murine sarcoma virus DNA. | Q35237929 | ||
| Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus | Q35371969 | ||
| Transforming activity of human tumor DNAs | Q35426142 | ||
| Activation of related transforming genes in mouse and human mammary carcinomas | Q35469217 | ||
| High-frequency cotransfer of the transformed phenotype and a tumor-specific transplantation antigen by DNA from the 3-methylcholanthrene-induced Meth A sarcoma of BALB/c mice | Q36383218 | ||
| Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus | Q36507362 | ||
| Proposal for Naming Host Cell-Derived Inserts in Retrovirus Genomes | Q40144761 | ||
| Transforming activity of DNA of chemically transformed and normal cells | Q41643023 | ||
| Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts | Q42801594 | ||
| Stage-specific transforming genes of human and mouse B- and T-lymphocyte neoplasms | Q42825643 | ||
| Transforming genes of neoplasms induced by avian lymphoid leukosis viruses | Q42827989 | ||
| Three different human tumor cell lines contain different oncogenes | Q43550250 | ||
| Two distinct candidate transforming genes of lymphoid leukosis virus-induced neoplasms | Q44043353 | ||
| Identification of a normal vertebrate cell protein related to the p21 src of harvey murine sarcoma virus | Q45802956 | ||
| Transformation by subgenomic fragments of Rous sarcoma virus DNA. | Q45803606 | ||
| The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes | Q53570306 | ||
| Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis | Q53571550 | ||
| Enemies within: the genesis of retrovirus oncogenes. | Q53573208 | ||
| Unique transforming gene in carcinogen-transformed mouse cells | Q59064828 | ||
| Heterotransplantation of human cancers into nude mice: a model system for human cancer chemotherapy | Q67415554 | ||
| Activation of the Transforming Potential of a Normal Cell Sequence: A Molecular Model for Oncogenesis | Q70777146 | ||
| A tumor-specific membrane phosphoprotein marker in human cell hybrids | Q71063417 | ||
| Plasmid screening at high colony density | Q72148661 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung carcinoma | Q18556110 |
| P304 | page(s) | 3637-3640 | |
| P577 | publication date | 1982-06-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses | |
| P478 | volume | 79 |
| Q37408568 | A GTP-binding protein of Escherichia coli has homology to yeast RAS proteins |
| Q42819141 | A Transforming ras Gene in Tumorigenic Guinea Pig Cell Lines Initiated by Diverse Chemical Carcinogens |
| Q42635684 | A bacterial toxin that cleaves Ras oncoprotein |
| Q57382481 | A cellular oncogene (c-Ki-ras) is amplified, overexpressed and located within karyotypic abnormalities in mouse adrenocortical tumour cells |
| Q59080605 | A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia |
| Q42290335 | A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer |
| Q37898108 | A new frontier in personalized cancer therapy: mapping molecular changes. |
| Q36911465 | A new oncogene, c-raf, is located on mouse chromosome 6. |
| Q42817664 | A novel transforming gene in a human malignant melanoma cell line |
| Q28279136 | A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene |
| Q37565544 | A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient |
| Q27929849 | A product of yeast RAS2 gene is a guanine nucleotide binding protein |
| Q28264768 | A transforming gene present in human sarcoma cell lines |
| Q37085887 | ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer |
| Q39561478 | ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein |
| Q28275191 | Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene |
| Q38222722 | Activated K-RAS and its effect on morphological appearance. |
| Q36917943 | Activated K-ras and N-ras oncogenes in primary renal mesenchymal tumors induced in F344 rats by methyl(methoxymethyl)nitrosamine |
| Q48396942 | Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations |
| Q42819366 | Activation of N-ras gene in bone marrow cells from a patient with acute myeloblastic leukaemia |
| Q24618187 | Activation of N-ras in a human melanoma cell line |
| Q48401500 | Activation of a cellular oncogene by DNA rearrangement: possible involvement of an IS-like element |
| Q35477612 | Activation of a human c-K-ras oncogene |
| Q24568201 | Activation of an N-ras gene in acute myeloblastic leukemia through somatic mutation in the first exon |
| Q34280682 | Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. |
| Q40237699 | Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas |
| Q42832911 | Alterations of mouse proto-oncogenes in sarcomas induced after transplantation of human tumors in athymic nude mice |
| Q35270995 | Amplified DNA in Y1 mouse adrenal tumor cells: isolation of cDNAs complementary to an amplified c-Ki-ras gene and localization of homologous sequences to mouse chromosome 6. |
| Q35010156 | An Update on the Biology of RAS/RAF Mutations in Colorectal Cancer |
| Q53542695 | Anti-oncogenes. A subset of regulatory genes involved in carcinogenesis? |
| Q44805261 | Application of reductive ¹³C-methylation of lysines to enhance the sensitivity of conventional NMR methods. |
| Q37204679 | Applications of genomics in melanoma oncogene discovery |
| Q70182304 | Assignment of murine cellular HarveyRas gene to chromosome 7 |
| Q52827198 | BALB and kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent BALB/c mouse epidermal keratinocyte lines |
| Q36915093 | Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts |
| Q69194909 | Benzo[a]pyrene-diol-epoxide-induced anchorage-independence in diploid human fibroblasts. Analysis of cellular protooncogenes |
| Q40658346 | Biochemical and biological properties of the human N-ras p21 protein |
| Q40872306 | Biochemical markers for colorectal cancer. Diagnostic and therapeutic implications |
| Q42817584 | Biological properties of human c-Ha-ras1 genes mutated at codon 12. |
| Q36466131 | Bladder cancer cell line cross-contamination: identification using a locus-specific minisatellite probe |
| Q37148184 | Cancer genome sequencing and its implications for personalized cancer vaccines |
| Q59058462 | Cancer: The Ras renaissance |
| Q33934143 | Cell surface glycolipids of transformed NIH 3T3 cells transfected with DNAs of human bladder and lung carcinomas |
| Q40161805 | Cellular Oncogenes and Multistep Carcinogenesis |
| Q34253517 | Cellular Transforming Genes |
| Q24615673 | Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene |
| Q35581673 | Characterization of KRAS rearrangements in metastatic prostate cancer |
| Q59086201 | Characterization of a human colon/lung carcinoma oncogene |
| Q28211237 | Characterization of the novel amplified in breast cancer-1 (NABC1) gene product |
| Q28768656 | Chemical carcinogens: a review of the science and its associated principles. U.S. Interagency Staff Group on Carcinogens |
| Q37956450 | Chromosomal abnormalities in human breast cancer |
| Q37343050 | Chromosomal assignment of a family of human oncogenes |
| Q68037045 | Chromosomal changes in cell lines from mouse tumors induced by nickel sulfide and methylcholanthrene |
| Q53563938 | Chromosomal localization of human cellular homologues of two viral oncogenes. |
| Q35687862 | Chromosomal localization of the human c-fms oncogene |
| Q69848461 | Chromosomal markers in study of colon cancer |
| Q41571752 | Co-transfection of normal NIH/3T3 DNA and retroval LTR sequences: a novel strategy for the detection of potential c-onc genes |
| Q48399601 | Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue |
| Q39581697 | Control of myogenic differentiation by cellular oncogenes |
| Q42798594 | Correlation between Ha-ras gene amplification and spontaneous metastasis in NIH 3T3 cells transfected with genomic DNA from human skin cancers. |
| Q40077580 | Current Understanding of Virus Etiology in Leukemia |
| Q35108242 | Deficiency of a potential 3p21.3 tumor suppressor gene UBE1L (UBA7) does not accelerate lung cancer development in K-rasLA2 mice |
| Q52500097 | Detection of a molecular complex between ras proteins and transferrin receptor |
| Q37531654 | Detection of a raf-related and two other transforming DNA sequences in human tumors maintained in nude mice |
| Q36901535 | Development and analysis of a transformation-defective mutant of Harvey murine sarcoma tk virus and its gene product. |
| Q34189296 | Dictyostelium: an ideal organism for genetic dissection of Ras signalling networks. |
| Q40700323 | Differential expression of cholinephosphotransferase in normal and cancerous human mammary epithelial cells |
| Q33931394 | Differential methylation of the c-H-ras gene in normal mouse cells and during skin tumour progression |
| Q36908523 | Direct identification of palmitic acid as the lipid attached to p21ras |
| Q38911598 | Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design |
| Q61809925 | Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction |
| Q43557489 | Dispersion of the ras family of transforming genes to four different chromosomes in man. |
| Q36570897 | Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers |
| Q37672156 | Effects of two major activating lesions on the structure and conformation of human ras oncogene products |
| Q47443285 | Efforts to Develop KRAS Inhibitors |
| Q39026766 | Endometrial Carcinoma: Specific Targeted Pathways. |
| Q35594513 | Enhanced c-Ki-ras expression associated with Friend virus integration in a bone marrow-derived mouse cell line |
| Q42818380 | Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins |
| Q41145938 | Evaluation of a monoclonal antibody to ras peptide, RAP-5, claimed to bind preferentially to cells of infiltrating carcinomas |
| Q40676030 | Expression and characterization of ras mRNAs from Saccharomyces cerevisiae |
| Q45827877 | Expression of abl and other oncogenes is independent of metastatic potential in Abelson virus-transformed malignant murine large cell lymphoma |
| Q34245213 | Expression of normal and transforming H-ras genes in Escherichia coli and purification of their encoded p21 proteins |
| Q37680820 | Expression of p21ras in fresh primary and metastatic human colorectal tumors |
| Q34622969 | Expression of p21ras in normal and malignant human tissues: lack of association with proliferation and malignancy |
| Q35875152 | Expression, Purification, and Characterization of Ras Protein (BmRas1) from Bombyx mori |
| Q52857898 | FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma. |
| Q28218688 | Fortuitous convergences: the beginnings of JUN |
| Q36993193 | Free radicals in chemical carcinogenesis |
| Q37690563 | Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors |
| Q53559358 | Frequent Activation of c- kis as a Transforming Gene in Fibrosarcomas Induced by Methylcholanthrene |
| Q38103175 | Function of oncogenes in cancer development: a changing paradigm |
| Q39656079 | Genes and cancer: a clinical perspective. |
| Q41659418 | Genes involved in oncogenesis. |
| Q37345944 | Genetic analysis of the 15;17 chromosome translocation associated with acute promyelocytic leukemia |
| Q34145806 | Genomic and biological characterization of exon 4 KRAS mutations in human cancer |
| Q41966335 | Glucagon and p21 ras enhance the phosphorylation of the same 38-kilodalton membrane protein from rat liver cells |
| Q93045200 | Glycyrrhetinic acid binds to the conserved P-loop region and interferes with the interaction of RAS-effector proteins |
| Q37576661 | Guanosine nucleotide binding by highly purified Ha-ras-encoded p21 protein produced in Escherichia coli. |
| Q37948622 | HPV, KRAS mutations, alcohol consumption and tobacco smoking effects on esophageal squamous-cell carcinoma carcinogenesis. |
| Q42818690 | Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours |
| Q37673948 | Ha-ras proteins exhibit GTPase activity: point mutations that activate Ha-ras gene products result in decreased GTPase activity |
| Q33267389 | High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer. |
| Q59086195 | Homology between human bladder carcinoma oncogene product and mitochondrial ATP-synthase |
| Q36946669 | Human Colon Carcinoma Ki-ras2 Oncogene and Its Corresponding Proto-Oncogene |
| Q24625952 | Human N-ras: cDNA cloning and gene structure |
| Q36081239 | Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression |
| Q39668510 | Human cancer and cellular oncogenes |
| Q24683663 | Human herpesvirus 6 |
| Q35844971 | Human herpesvirus 6A ts suppresses both transformation by H-ras and transcription by the H-ras and human immunodeficiency virus type 1 promoters |
| Q70339238 | Human oncogenes |
| Q30959617 | Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia |
| Q36597912 | Identification and molecular cloning of the human Blym transforming gene activated in Burkitt's lymphomas. |
| Q37549894 | Identification by transfection of transforming sequences in DNA of human T-cell leukemias |
| Q29619131 | Identification of genes periodically expressed in the human cell cycle and their expression in tumors |
| Q34254574 | Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1. |
| Q42799320 | Identity of some human bladder cancer cell lines |
| Q41790358 | Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms |
| Q37094517 | Importance of oncogene research to the cancer clinician |
| Q53556700 | Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations. |
| Q37980724 | Inhibition and termination of physiological responses by GTPase activating proteins |
| Q36900547 | Inhibitory effect of interferon on the genetic and oncogenic transformation by viral and cellular genes. |
| Q36267430 | Isolation and characterization of a stage-specific transforming gene, Tlym-I, from T-cell lymphomas |
| Q28265250 | Isolation and preliminary characterization of the transforming gene of a human neuroblastoma cell line |
| Q24618042 | Isolation of duplicated human c-src genes located on chromosomes 1 and 20 |
| Q36244681 | Isolation of transforming sequences of two human lung carcinomas: structural and functional analysis of the activated c-K-ras oncogenes. |
| Q36597411 | Isolation of v-fms and its human cellular homolog |
| Q40434681 | K-ras mutation and pancreatic adenocarcinoma |
| Q37261936 | KRAS - An Evolving Cancer Target |
| Q57072901 | KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer |
| Q36872978 | KRAS and BRAF mutation analysis in colorectal adenocarcinoma specimens with a low percentage of tumor cells. |
| Q37815135 | KRAS and BRAF: drug targets and predictive biomarkers |
| Q34643960 | KRAS mutation testing in metastatic colorectal cancer |
| Q49887897 | KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target |
| Q26751212 | Kirsten Ras* oncogene: Significance of its discovery in human cancer research |
| Q38956084 | Latest Advances Towards Ras Inhibition: A Medicinal Chemistry Perspective. |
| Q35197594 | Localization of HeLa cell tumor-suppressor gene to the long arm of chromosome II. |
| Q37344757 | Localization of c-ras oncogene family on human germ-line chromosomes |
| Q28265670 | Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia |
| Q44611368 | Localization of the normal allele of T24 human bladder carcinoma oncogene to chromosome 11. |
| Q37537053 | Loss of the normal N-ras allele in a mouse thymic lymphoma induced by a chemical carcinogen |
| Q38642874 | Malignant transformation of mammalian cells in culture, including human cells |
| Q40667295 | Malignant transformation of murine fibroblasts by a human c-Ha-ras-1 oncogene does not require a functional epidermal growth factor receptor |
| Q37056216 | Many roads lead to oncogene-induced senescence |
| Q29616165 | Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome |
| Q34708285 | Mechanism of activation of a human oncogene |
| Q24555646 | Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080 |
| Q24595622 | Mechanism of activation of an N-ras oncogene of SW-1271 human lung carcinoma cells |
| Q36946976 | Metabolic turnover of human c-rasH p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs |
| Q35708595 | Methotrexate and Ras methylation: a new trick for an old drug? |
| Q34613693 | Mice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatally |
| Q38548766 | MicroRNA-Based Therapeutic Strategies for Targeting Mutant and Wild Type RAS in Cancer |
| Q40659244 | Molecular cloning and characterization of an activated human c-raf-1 gene |
| Q35436153 | Molecular cloning and chromosome assignment of murine N-ras |
| Q48399510 | Molecular cloning and nucleotide sequence of a transforming gene detected by transfection of chicken B-cell lymphoma DNA. |
| Q33931037 | Molecular cloning and sequence analysis of a ras gene from Schizosaccharomyces pombe |
| Q37529389 | Molecular cloning of an activated human oncogene, homologous to v-raf, from primary stomach cancer |
| Q35616027 | Molecular cloning of an oncogene from a human hepatocellular carcinoma |
| Q30486859 | Molecular genetic aspects of human cancers: the 1993 Frank Rose Lecture |
| Q41316822 | Molecularly cloned c-mos(rat) is biologically active |
| Q42817693 | Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases |
| Q44412765 | Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. II. Identification of the cellular target structures by immunoprecipitation and SDS-PAGE analysis |
| Q37402048 | Monoclonal antibody specific for an activated RAS protein |
| Q36976043 | Mouse Cells Contain Two Distinct ras Gene mRNA Species That Can Be Translated into a p21 onc Protein |
| Q42823403 | Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene |
| Q40160337 | Multi-step genetic regulation of oncogene expression in fish hereditary melanoma |
| Q40951665 | Mutation and cancer: a personal odyssey |
| Q37659757 | NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformation |
| Q42807573 | Negative regulation of Par-4 by oncogenic Ras is essential for cellular transformation |
| Q36947151 | New Human Transforming Genes Detected by a Tumorigenicity Assay |
| Q37671224 | New insights into the causes of cancer. |
| Q36931107 | New mammalian transforming retrovirus: demonstration of a polyprotein gene product |
| Q45056728 | Newly generated avian erythroblastosis virus produces noninfectious particles lacking env-gene products |
| Q43506385 | No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases |
| Q37610817 | Non-redundancy within the RAS oncogene family: insights into mutational disparities in cancer |
| Q36899738 | Nucleotide sequence analysis of the BALB/c murine sarcoma virus transforming gene |
| Q35745133 | Of mice and Myc: c-Myc and mammary tumorigenesis |
| Q39559546 | Oncogene activation in chemical carcinogenesis |
| Q67261188 | Oncogene from Human EJ Bladder Carcinoma Is Located on the Short Arm of Chromosome 11 |
| Q40203216 | Oncogene research: closing in on a better understanding of cancer causation |
| Q36016428 | Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer |
| Q72706483 | Oncogenes |
| Q40179507 | Oncogenes and Cancer: The p21rasGenes |
| Q40169999 | Oncogenes and cancer |
| Q44714658 | Oncogenes and cancer |
| Q39642389 | Oncogenes and gastrointestinal cancer |
| Q41434398 | Oncogenes and the molecular biology of cancer |
| Q39158285 | Oncogenes and transcriptional control |
| Q35034093 | Oncogenes and tumor-suppressor genes |
| Q28279392 | Oncogenes in solid human tumours |
| Q40077738 | Oncogenes of Human Tumour Cells A Review of Advances in Virology and Molecular Biology of Cancer |
| Q39743389 | Oncogenes, cancer and analytical cytology |
| Q40170416 | Oncogenes: Clues to carcinogenesis |
| Q42810073 | Oncogenic Ras sensitizes cells to apoptosis by Par-4. |
| Q41547255 | Oncogenic genes and human malignancy |
| Q40952636 | Oncolytic reovirus induces intracellular redistribution of Ras to promote apoptosis and progeny virus release. |
| Q69363186 | Origin of rare Ha-ras alleles: relationship of VTR length to a 5' polymorphic Xho I site |
| Q38704331 | PP6 Disruption Synergizes with Oncogenic Ras to Promote JNK-Dependent Tumor Growth and Invasion |
| Q36233709 | Pathogenesis of lung cancer: 100 year report |
| Q41557211 | Persistence of cell cycle times over many generations as determined by heritability of colony sizes of ras oncogene-transformed and non-transformed cells |
| Q36915056 | Photoaffinity labeling with GTP of viral p21 ras protein expressed in Escherichia coli |
| Q40660881 | Platelet-derived growth factor does not induce c-fos in NIH 3T3 cells expressing the EJ-ras oncogene |
| Q53029822 | Polymorphism of the human HA-RAS oncogene locus in chronic lymphocytic and chronic myelogenous leukemia |
| Q92627793 | Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles |
| Q60305725 | Predicting protein targets for drug-like compounds using transcriptomics |
| Q37347232 | Prediction of the three-dimensional structure of the transforming region of the EJ/T24 human bladder oncogene product and its normal cellular homologue |
| Q36981182 | Presence of a Kirsten Murine Sarcoma Virus ras Oncogene in Cells Transformed by 3-Methylcholanthrene |
| Q37566819 | Prevalence of driver mutations in non-small-cell lung cancers in the People's Republic of China. |
| Q64058272 | Pro-apoptotic and pro-proliferation functions of the JNK pathway of Drosophila: roles in cell competition, tumorigenesis and regeneration |
| Q35451756 | Proto-oncogenes and germ-cell differentiation |
| Q37420705 | Proto-oncogenes in development and cancer |
| Q42824608 | Purification from transformed mouse fibroblast of a cell growth inhibitor which is an IGF-binding protein |
| Q36284491 | RAS genes and growth control in Saccharomyces cerevisiae |
| Q55036584 | RAS oncogenes: the first 30 years. |
| Q40124496 | RETRACTED: A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern |
| Q40139945 | RNA-tumorviruses, oncogenes, and their possible role in human carcinogenesis |
| Q36902553 | Rapid induction of hemopoietic neoplasms in newborn mice by a raf(mil)/myc recombinant murine retrovirus |
| Q52721338 | Ras and Rap1: A tale of two GTPases. |
| Q30404024 | Ras history: The saga continues |
| Q34202697 | Ras in cancer and developmental diseases |
| Q29615405 | Ras oncogenes: split personalities |
| Q35062420 | Ras redux: rethinking how and where Ras acts. |
| Q30244673 | Rationale for RAS mutation-tailored therapies. |
| Q30486899 | Recessive mechanisms of malignancy |
| Q36781853 | Recombinant BALB and Harvey sarcoma viruses with normal proto-ras-coding regions transform embryo cells in culture and cause tumors in mice |
| Q35607598 | Reduced hormone-stimulated adenylate cyclase activity in NIH-3T3 cells expressing the EJ human bladder ras oncogene |
| Q36944718 | Regional Localization of Two Human Cellular Kirsten ras Genes on Chromosomes 6 and 12 |
| Q35693730 | Regional chromosomal localization of N-ras, K-ras-1, K-ras-2 and myb oncogenes in human cells |
| Q36946333 | Regulated transcription of c-Ki-ras and c-myc during compensatory growth of rat liver |
| Q37970568 | Regulating the regulator: post-translational modification of RAS |
| Q37690837 | Resistance of human cells to tumorigenesis induced by cloned transforming genes |
| Q24611142 | Retroviral oncogenes: a historical primer |
| Q36752763 | Retroviral transduction of the human c-Ha-ras-1 oncogene into midgestation mouse embryos promotes rapid epithelial hyperplasia |
| Q40151708 | Retroviral transforming genes in normal cells? |
| Q54794454 | Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications. |
| Q51097608 | Runx3 and Cell Fate Decisions in Pancreas Cancer. |
| Q38835846 | STAT3 signaling in immunity |
| Q36940206 | Saccharomyces cerevisiae synthesizes proteins related to the p21 gene product of ras genes found in mammals |
| Q42507880 | Selection of transformed cells in serum-free media |
| Q72068776 | Separation of transforming N-ras mutations in codons 12, 13 and 61 by denaturing gradient gel electrophoresis : investigation based on a set of phagemid constructs |
| Q53829229 | Short-term activation of the Jun N-terminal kinase pathway in apoptosis-deficient cells of Drosophila induces tumorigenesis. |
| Q40872114 | Signal transduction pathways and their relevance in human astrocytomas |
| Q42804851 | Simultaneous transfer of tumorigenic and metastatic phenotypes by transfection with genomic DNA from a human cutaneous squamous cell carcinoma |
| Q27321600 | Single Synonymous Mutations in KRAS Cause Transformed Phenotypes in NIH3T3 Cells |
| Q34057932 | Small G-protein networks: their crosstalk and signal cascades. |
| Q40191686 | Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants |
| Q37344230 | Spontaneous activation of a human proto-oncogene |
| Q27682798 | Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy |
| Q45797728 | Structural and immunological similarities between simian sarcoma virus gene product(s) and human platelet-derived growth factor |
| Q36598671 | Structural organization and expression of human DNA sequences related to the transforming gene of avian myeloblastosis virus |
| Q33931245 | Structure and expression of amplified cKi-ras gene sequences in Y1 mouse adrenal tumor cells |
| Q28265475 | Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene |
| Q36905370 | Structure and transcription of the cellular homolog (c-myb) of the avian myeloblastosis virus transforming gene (v-myb). |
| Q34708404 | Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1. |
| Q24321945 | Subcellular localization of APMCF1 and its biological significance of expression pattern in normal and malignant human tissues |
| Q36888532 | Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes |
| Q35617240 | Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells |
| Q37780775 | Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas |
| Q35832710 | Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys |
| Q42020468 | Targeting oncogenic BRAF in human cancer |
| Q33679239 | Targeting protein prenylation for cancer therapy |
| Q37753517 | Targeting the mitogen-activated protein kinase pathway: physiological feedback and drug response |
| Q40154134 | The Emerging Genetics of Human Cancer |
| Q53560639 | The Human c- ras 1 H Oncogene: a Mutation in Normal and Neoplastic Tissue from the Same Patient |
| Q37358107 | The Kras2 oncogene and mouse lung carcinogenesis |
| Q35684596 | The N-ras oncogene assigned to the short arm of human chromosome 1. |
| Q40137529 | The Pathogenesis of Oncogenic Avian Retrovirusesxs |
| Q37159467 | The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders |
| Q37290440 | The RAS/mitogen activated protein (MAP) kinase pathway in melanoma biology and therapeutics |
| Q37956454 | The current state of oncogenes and cancer: experimental approaches for analyzing oncogenetic events in human cancer |
| Q36419929 | The discovery of HTLV-1, the first pathogenic human retrovirus |
| Q93270879 | The duality of human oncoproteins: drivers of cancer and congenital disorders |
| Q30398835 | The experiences of a biochemist in the evolving world of G protein-dependent signaling |
| Q24610004 | The history of tumor virology |
| Q35264991 | The human c-Ha-ras2 is a processed pseudogene inactivated by numerous base substitutions |
| Q34519801 | The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence |
| Q70379878 | The oncogenic circle closes |
| Q36841835 | The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation |
| Q77343239 | The p21-Ras signal transduction pathway and growth regulation in human high-grade gliomas |
| Q38840267 | The present and future of genome editing in cancer research |
| Q38740000 | The renewed battle against RAS-mutant cancers |
| Q36751714 | The role of cellular oncogenes in myogenesis and muscle cell hypertrophy |
| Q40159818 | The tumor phenotype and the human gene map |
| Q26747403 | The value of genomics in dissecting the RAS-network and in guiding therapeutics for RAS-driven cancers |
| Q28266043 | Three different activated ras genes in mouse tumours; evidence for oncogene activation during progression of a mouse lymphoma |
| Q37608532 | Three human transforming genes are related to the viral ras oncogenes |
| Q72127973 | Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21 |
| Q48225794 | Total Chemical Synthesis and Folding of All-l and All-d Variants of Oncogenic KRas(G12V). |
| Q38215923 | Toxicogenomics and cancer susceptibility: advances with next-generation sequencing. |
| Q36717548 | Transfected human beta-polymerase promoter contains a ras-responsive element |
| Q36896137 | Transfection of the EJ rasHa gene into keratinocytes derived from carcinogen-induced mouse papillomas causes malignant progression |
| Q42573442 | Transformation and stimulation of DNA synthesis in NIH-3T3 cells are a titratable function of normal p21N-ras expression. |
| Q36478421 | Transforming activity of DNA extracted from human urological tumours |
| Q39511011 | Transforming genes and target cells of murine spleen focus-forming viruses |
| Q37345502 | Transforming genes of human hematopoietic tumors: frequent detection of ras-related oncogenes whose activation appears to be independent of tumor phenotype |
| Q42819175 | Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity? |
| Q43479536 | Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein |
| Q34635101 | Tumor cell heterogeneity: divided-colony assay for measuring drug response |
| Q40139883 | Tumor viruses, oncogenes, and human cancer |
| Q28265486 | Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes |
| Q37848203 | Tumour-associated antigens: considerations for their use in tumour immunotherapy. |
| Q36327439 | Two human c-onc genes are located on the long arm of chromosome 8. |
| Q59058134 | Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients |
| Q35834890 | Vascular tumors produced by NIH/3T3 cells transfected with human AIDS Kaposi's sarcoma DNA. |
| Q33894872 | View and review on viral oncology research |
| Q33846198 | Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease |
| Q36870643 | What's new in the neuro-cardio-facial-cutaneous syndromes? |
| Q54903297 | LX-1 | described by source | P1343 |
Search more.